Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shashank Sama
Hyperprogression in PDL1 Expressive, Recurrent Gastroesophageal-Junction Adenocarcinoma After Pembrolizumab
Cureus
Related publications
The Role of Pembrolizumab in the Treatment of PD-L1 Expressing Gastric and Gastroesophageal Junction Adenocarcinoma
Therapeutic Advances in Gastroenterology
Gastroenterology
Radiomics Predicts Clinical Outcome in Primary Gastroesophageal Junction Adenocarcinoma Treated by Chemo/Radiotherapy and Surgery
Physics and Imaging in Radiation Oncology
Nuclear Medicine
Radiology
Radiation
Imaging
Oncology
Neoadjuvant Chemoradiotherapy or Chemotherapy for Gastroesophageal Junction Adenocarcinoma: A Systematic Review and Meta-Analysis
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Overview of Gastroesophageal Junction Cancers
Mini-invasive Surgery
New PDL1 Inhibitors for Non-Small Cell Lung Cancer: Focus on Pembrolizumab
OncoTargets and Therapy
Oncology
Pharmacology
Locally Advanced Gastroesophageal Junction Tumor: A Treatment Dilemma
Oncologist
Cancer Research
Medicine
Oncology
Prm18 - Real-World Data (Rwd) Collection Alongside Early Access to Medicines Schemes (Eams) - Nivolumab in Gastric or Gastroesophageal Junction Adenocarcinoma (Gc/Gej) After Two or More Prior Therapies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Multicenter Phase 2 Study of AMG 337 in Patients With MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
P51: The Expression of PD1/PDL1 in Peripheral Blood of Unexplained Recurrent Pregnancy Loss and Recurrent Implantation Failure Patients
American Journal of Reproductive Immunology
Gynecology
Reproductive Medicine
Immunology
Obstetrics
Allergy
